Michael Iskra
2021
In 2021, Michael Iskra earned a total compensation of $3.9M as Executive Vice President, Strategy & Commercial Excellence at Ortho Clinical Diagnostics Holdings plc.
Compensation breakdown
| Bonus | $35,000 |
|---|---|
| Non-Equity Incentive Plan | $299,136 |
| Salary | $490,385 |
| Stock Awards | $2,995,500 |
| Other | $35,528 |
| Total | $3,855,549 |
Iskra received $3M in stock awards, accounting for 78% of the total pay in 2021.
Iskra also received $35K in bonus, $299.1K in non-equity incentive plan, $490.4K in salary and $35.5K in other compensation.
Rankings
In 2021, Michael Iskra's compensation ranked 3,470th out of 12,406 executives tracked by ExecPay. In other words, Iskra earned more than 72.0% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 3,470 out of 12,406 | 72nd |
Division Manufacturing | 1,417 out of 5,492 | 74th |
Major group Chemicals And Allied Products | 572 out of 2,368 | 76th |
Industry group Drugs | 510 out of 2,089 | 76th |
Industry In Vitro and In Vivo Diagnostic Substances | 11 out of 61 | 82nd |
Source: SEC filing on May 2, 2022.
Iskra's colleagues
We found four more compensation records of executives who worked with Michael Iskra at Ortho Clinical Diagnostics Holdings plc in 2021.
2021
Christopher Smith
Ortho Clinical Diagnostics Holdings plc
Chief Executive Officer
2021
Michael Schlesinger
Ortho Clinical Diagnostics Holdings plc
General Counsel
2021
Joseph Busky
Ortho Clinical Diagnostics Holdings plc
Chief Financial Officer
2021
Chockalingam Palaniappan
Ortho Clinical Diagnostics Holdings plc